Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,807	1,997	1,581	1,928	1,551	1,326
Market Cap Growth	-2.09%	26.29%	-18.00%	24.34%	16.99%	6.52%
Enterprise Value	1,376	1,632	1,398	1,849	1,128	1,019
Last Close Price	32.27	36.16	28.94	35.67	29.16	25.16
PE Ratio	29.16	27.03	1201.42	31.76	29.03	10.44
Forward PE	14.94	19.65	15.34	30.84	15.73	15.73
PS Ratio	2.68	3.02	2.60	2.89	2.68	2.55
PB Ratio	1.75	1.93	1.72	2.18	1.90	1.78
P/TBV Ratio	4.39	5.03	7.73	28.90	-	4.38
P/FCF Ratio	11.06	11.66	14.30	16.56	12.40	9.84
P/OCF Ratio	11.01	11.61	14.23	16.51	12.20	9.58
PEG Ratio	-	1.11	1.11	1.11	1.11	1.11
EV/Sales Ratio	2.06	2.47	2.30	2.77	1.95	1.96
EV/EBITDA Ratio	9.92	11.51	14.23	14.10	10.06	5.26
EV/EBIT Ratio	23.47	26.59	104.31	40.53	14.18	5.80
EV/FCF Ratio	8.42	9.53	12.65	15.88	9.01	7.56
Debt / Equity Ratio	0.03	0.03	0.05	0.51	0.54	0.59
Debt / EBITDA Ratio	0.21	0.22	0.37	3.13	3.55	2.17
Debt / FCF Ratio	0.20	0.20	0.38	3.87	3.52	3.24
Asset Turnover	0.50	0.50	0.41	0.39	0.36	0.39
Inventory Turnover	1.24	1.18	0.99	0.98	1.12	1.40
Quick Ratio	2.16	2.04	1.38	0.91	1.55	2.30
Current Ratio	2.44	2.35	1.70	1.07	1.91	2.57
Return on Equity (ROE)	6.32%	7.55%	0.15%	7.13%	6.85%	18.94%
Return on Assets (ROA)	2.76%	2.90%	0.56%	1.68%	3.11%	8.24%
Return on Capital (ROIC)	3.60%	3.77%	0.73%	2.20%	4.08%	10.08%
Return on Capital Employed (ROCE)	5.50%	5.70%	1.40%	4.50%	5.80%	13.90%
Earnings Yield	3.43%	3.70%	0.08%	3.15%	3.45%	9.58%
FCF Yield	9.04%	8.58%	6.99%	6.04%	8.07%	10.16%
Buyback Yield / Dilution	-2.52%	-0.81%	10.01%	-13.47%	-1.24%	0.24%

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q